- Tesla, Inc. (TSLA) shares fell 1.6% after Reuters reports that the company plans to produce a six-seat version of its Model Y in China starting in late 2025
- Shares of Vaxcyte, Inc. (PCVX) surged 36.4% after positive Phase 1/2 results for its 31-valent pneumococcal vaccine
- CleanSpark, Inc. (CLSK) shares tumbled 15.6% after its August update showed a drop in bitcoin production compared to previous months.
- Shares of Vistra (VST) plunged 11.3% as investors sold off the stock to lock in profits after its 120% gain this year.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>Tesla, Inc. (TSLA) : Free Stock Analysis Report
Vistra Corp. (VST) : Free Stock Analysis Report
Cleanspark, Inc. (CLSK) : Free Stock Analysis Report
Vaxcyte, Inc. (PCVX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
